Atlas Global Brands Past Earnings Performance
Past criteria checks 2/6
There is insufficient data on Atlas Global Brands's performance over the last few years.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Pharmaceuticals Industry Growth | 23.1% |
Revenue growth rate | n/a |
Return on equity | 81.3% |
Net Margin | n/a |
Last Earnings Update | 31 Dec 2022 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses BreakdownBeta
How Atlas Global Brands makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 22 | 0 | 26 | 2 | 0 |
Quality Earnings: ATL has a high level of non-cash earnings.
Growing Profit Margin: ATL became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Unable to establish if ATL's year-on-year earnings growth rate was positive over the past 5 years as it has been trading publicly for less than 3 years.
Accelerating Growth: Unable to compare ATL's past year earnings growth to its 5-year average as it has been trading publicly for less than 3 years.
Earnings vs Industry: ATL has become profitable in the last year, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (109.7%).
Return on Equity
High ROE: ATL's Return on Equity (81.3%) is considered outstanding.